Skip to main content
SpringerLink
Log in

Primary central nervous system lymphoma in Japan 1995–1999: changes from the preceding 10 years

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Previously, we conducted a nationwide survey of primary central nervous system lymphoma (PCNSL) treated between 1985 and 1994 in Japan. In the present study, we conducted further investigations of PCNSL patients treated between 1995 and 1999 to clarify possible changes with time in the clinical features, treatment, and outcome of this disease.

Methods

Thirteen Japanese institutions were surveyed, and data on 101 patients with histologically-confirmed PCNSL were collected. These data were compared with those of 167 patients treated at the same institutions between 1985 and 1994.

Results

Regarding patient and tumor characteristics, the proportion of patients with good performance status (PS) was significantly higher in the group treated during 1995–1999 than in that treated during 1985–1994, but other characteristics were not significantly different. Regarding treatment, more patients in the more recent period (66%) received systemic chemotherapy than those in the preceding period (53%, P = 0.049). For all patients, including those who did not complete radiotherapy, the median survival time was 17 months and 30 months in patients treated between 1985 and 1994 and those treated between 1995 and 1999, respectively, and the 5-year survival rate was 15% versus 31% (P = 0.0003). In both patient groups, higher age and tumor multiplicity were associated with poor prognosis in multivariate analysis. In patients treated between 1995 and 1999, those who received systemic chemotherapy showed significantly better prognosis than those who did not (P = 0.0049), but the difference was not significant in multivariate analysis (P = 0.23).

Conclusions

The high survival rates observed in the present survey are comparable with those of recent prospective studies employing intensive chemoradiotherapy. The improvement in prognosis appeared to result, at least in part, from the increase in the proportion of patients with better PS. Since the clinical feature and treatment outcome of patients with PCNSL can thus change with the era, historical control data should not be used in comparing different treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Abrey LE, Yahalom J, DeAngelis LM (2000) Treatment for primary CNS lymphoma: the next step. J Clin Oncol 18:3144–3150

    CAS  PubMed  Google Scholar 

  • Bessell EM, Graus F, Lopez-Guillermo A, Villa S, Verger E, Petit J, Holland I, Byrne P (2001) CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 50:457–464

    Article  CAS  PubMed  Google Scholar 

  • Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H, Bouabdallah R, Coiffier B, Wagner JP, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F, Biron P (1998) High-dose MTX for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16:864–871

    CAS  PubMed  Google Scholar 

  • Brada M, Hjiyiannakis D, Hines F, Traish D, Ashley S (1998) Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma. Int J Radiat Oncol Biol Phys 40:1157–1162

    CAS  PubMed  Google Scholar 

  • Calderoni A, Aebi S (2002) Combination chemotherapy with high-dose MTX and cytarabine with or without brain irradiation for primary central nervous system lymphomas. J Neurooncol 59:227–230

    Article  PubMed  Google Scholar 

  • Corry J, Smith JG, Wirth A, Quong G, Liew KH (1998) Primary central nervous system lymphoma: age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41:615–620

    Article  CAS  PubMed  Google Scholar 

  • DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93–10. J Clin Oncol 20:4643–4648

    Article  PubMed  Google Scholar 

  • Ferreri AJM, Reni M, Villa E (2000) Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 11:927–937

    Article  CAS  PubMed  Google Scholar 

  • Glass J, Gruber ML, Chef L, Hochberg FH (1994) Preirradiation MTX chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81:188–195

    CAS  PubMed  Google Scholar 

  • Hayabuchi N, Shibamoto Y, Onizuka Y, JASTRO CNS Lymphoma Study Group members (1999) Primary central nervous system lymphoma in Japan: a nationwide survey. Int J Radial Oncol Biol Phys 44:265–272

    Article  CAS  Google Scholar 

  • Herrlinger U, Schabet M, Brugger W, Kortmann RD, Kuker W, Deckert M, Engel C, Schmeck-Lindenau HJ, Mergenthaler HG, Krauseneck P, Benohr C, Meisner C, Wiestler OD, Dichgans J, Kanz L, Bamberg M, Weller M (2002) German Cancer Society Neuro-Oncology Working Group NOA-03 multi-center trial of single-agent high-dose MTX for primary central nervous system lymphoma. Ann Neurol 51:247–252

    CAS  PubMed  Google Scholar 

  • Mead GM, Bleehen NM, Gregor A, Bullimore J, Shirley D, Rampling RP, Trevor J, Glaser MG, Lantos P, Ironside JW, Moss TH, Brada M, Whaley JB, Stenning SP (2000) A Medical Research Council randomized trial in patients with primary central non-Hodgkin’s lymphoma. Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 89:1359–1370

    CAS  PubMed  Google Scholar 

  • Nelson DF (1999) Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL). J Neuro-Oncol 43:241–247

    Google Scholar 

  • Nelson DF, Martz KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KJ (1992) Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radial Oncol Biol Phys 23:9–17

    CAS  Google Scholar 

  • O’Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, Olver I, Trotter G (2000) Phase II multicenter study of brief single-agent MTX followed by irradiation in primary CNS lymphoma. J Clin Oncol 18:519–526

    CAS  PubMed  Google Scholar 

  • O’Neill BP, O’Fallon JR, Earle JD, Colgan JD, Earle JD, Krigel RL, Brown LD, McGinnis WL (1999) Primary central nervous system non-Hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) study 86–72–52. Int J Radiat Oncol Biol Phys 43:559–563

    Article  CAS  PubMed  Google Scholar 

  • Reni M, Ferreri AJM, Garancini MP, Villa E (1997) Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Onco1 8:227–234

    Article  CAS  Google Scholar 

  • Reni M, Ferreri AJ, Guha-Thakurta N, Blay JY, Dell’Oro S, Biron P, Hochberg FH (2001) Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose MTX. Int J Radiat Oncol Biol Phys 51:419–425

    CAS  PubMed  Google Scholar 

  • Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom J (1996) Preirradiation chemotherapy with cyclophosphamide doxorubicin, vincristine, and dexamethazone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88–06. J Clin Oncol 14:556–564

    CAS  PubMed  Google Scholar 

  • Shibamoto Y, Tsutsui K, Dodo Y, Yamabe H, Shima N, Abe M (1990) Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 65:1907–1912

    CAS  PubMed  Google Scholar 

  • Shibamoto Y, Sasai K, Oya N, Hiraoka M (1999) Systemic chemotherapy with vincristine, cyclophosphamide, doxorubicin and prednisolone following radiotherapy for primary central nervous system lymphoma: a phase II study. J Neurooncol 42:161–167

    Article  CAS  PubMed  Google Scholar 

  • Shibamoto Y, Hayabuchi N, Hiratsuka J, Tokumaru S, Shirato H, Sougawa M, Oya N, Uematsu Y, Hiraoka M (2003) Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence following partial-brain irradiation. Cancer 97:128–133

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (14030042, 14370276, 14657214). The authors wish to thank Drs. Kumiko Karasawa, Atsushi Nishikawa, Naoto Shikama, Koichi Isobe, and Kuniaki Katsui for valuable help in collecting data.

Author information

Authors and Affiliations

  1. Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, 467-8601, Mizuho-ku, Nagoya , Japan

    Yuta Shibamoto

  2. JASTRO CNS Lymphoma Study Group, Japan

    Yuta Shibamoto, Emiko Tsuchida, Kaori Seki, Natsuo Oya, Masatoshi Hasegawa, Yukihiro Toda, Mitsuhiro Takemoto, Minako Sumi, Jun-ichi Hiratsuka, Masahiko Oguchi, Masako Hosono, Shigeo Yasuda, Mitsuharu Sougawa, Yoshihisa Kakutoh & Naofumi Hayabuchi

Authors
  1. Yuta Shibamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emiko Tsuchida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaori Seki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natsuo Oya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masatoshi Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yukihiro Toda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mitsuhiro Takemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Minako Sumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jun-ichi Hiratsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Masahiko Oguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Masako Hosono
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shigeo Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Mitsuharu Sougawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yoshihisa Kakutoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Naofumi Hayabuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuta Shibamoto.

Additional information

Author affiliations are: Niigata University (ET), Tokyo Women’s Medical University (KS), Kyoto University (NO), Gunma University (M Hasegawa), Kurume University (YT, NH), Okayama University (MT), National Cancer Center (M Sumi), Kawasaki Medical School (JH), Cancer Research Institute (MO), Osaka City University (M Hosono), Chiba University (SY), Kansai Medical University (M Sougawa), and Tohoku University (YK)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shibamoto, Y., Tsuchida, E., Seki, K. et al. Primary central nervous system lymphoma in Japan 1995–1999: changes from the preceding 10 years. J Cancer Res Clin Oncol 130, 351–356 (2004). https://doi.org/10.1007/s00432-004-0547-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-004-0547-x

Keywords

Search

Navigation